WASHINGTON, May 25 (Reuters) - Aegerion Pharmaceuticals Inc. on Friday set its planned initial public offering at 5 million shares for between $12 and $14 per share.
WASHINGTON, May 25 (Reuters) - Aegerion Pharmaceuticals Inc. on Friday set its planned initial public offering at 5 million shares for between $12 and $14 per share.